Overground Virtual Reality (VR) Gait Rehabilitation for Stroke
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIndiana University
About this trial
The purpose of this study is to evaluate a new virtual reality (VR)-based rehabilitation program designed to help stroke survivors improve their walking abilities in real-world settings. By comparing immersive VR-assisted overground gait therapy to contemporary non-immersive, treadmill-based VR therapy (i.e., C-Mill), the investigators aim to determine its effectiveness in enhancing mobility and quality of life for stroke survivors.
Eligibility criteria
Qualifiers
Diagnosis: Anischemic or hemorrhagic stroke verified by imaging, confirmed by the patient's physician, and 1-6 months post-stroke (subacute phase)
Motor Impairment Level: Functional Ambulation Category (FAC) 3-5, showing moderate impairment while still allowing safe participation in gait tasks.
Cognitive Function: Mini-Mental State Examination (MMSE) score ≥ 24 or Montreal Cognitive Assessment (MoCA) score >= 20, indicating sufficient cognitive function to participate in the study.
Exercise Clearance: Approval from a physician for participation in exercise- and VR-based interventions.
Disqualifiers
Participants with uncontrolled cardiovascular, orthopedic, or metabolic conditions or unstable medication regimens that could interfere with their participation in the study.
Any comorbidity that could interfere with walking or gait training.
Participation in robot- or VR-assisted gait training within the last 6 months.
Intolerance to virtual reality environments or motion simulation.
Trial design
Treatments tested in this trial
- Walk-over-Ground
- C-Mill VR+ by Motek
Treatment groups
30 Participants
are divided into 2 treatment groupsLocations
1Indiana University Health, Neurorehabilitation & Robotics46202, IndianapolisIndiana, United States
Sponsors and collaborators
Indiana University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Source ClinicalTrials.gov